We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Arecor Therapeutics Plc | LSE:AREC | London | Ordinary Share | GB00BMWLM973 | ORD GBP0.01 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 158.50 | 157.00 | 160.00 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 160.00 | 158.50 | 158.50 | 18,730 | 09:32:45 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | 3.54M | -9.26M | -0.3024 | -5.29 | 49M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 21/5/2024 | 07:00 | UK RNS | Arecor Therapeutics PLC Arecor to host company and KOL webinar today |
| 20/5/2024 | 09:58 | ALNC |  Arecor Therapeutics hails positive profile for insulin AT278 |
| 20/5/2024 | 07:00 | UK RNS | Arecor Therapeutics PLC Positive headline results for AT278 clinical trial |
| 16/5/2024 | 14:32 | ALNC | EARNINGS AND TRADING: Michelmersh continues with positive order intake |
| 16/5/2024 | 07:00 | UK RNS | Arecor Therapeutics PLC Final results for 2023 |
| 14/5/2024 | 10:17 | UK RNS | Arecor Therapeutics PLC Notice of Results |
| 09/5/2024 | 17:18 | ALNC | Arecor Therapeutics collaborates with Medtronic on novel insulin |
| 09/5/2024 | 07:00 | UK RNS | Arecor Therapeutics PLC Arecor and Medtronic Diabetes collaboration |
| 03/5/2024 | 18:02 | ALNC | IN BRIEF: Arecor Therapeutics delays publication of 2023 results |
| 03/5/2024 | 16:44 | UK RNS | Arecor Therapeutics PLC Publication of Full Year Financial Results delayed |
1 Year Arecor Therapeutics Chart |
Intraday Arecor Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
